Articles From: Ignyta Receives Approval of Nonproprietary Name Entrectinib for Lead Product Candidate, RXDX-101 to Big trouble in China as oil's slide inspires visions of world peace

Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, today announced that the World Health Organization (WHO) has approved the international nonproprietary name (INN) “entrectinib” for the company’s lead product candidate, RXDX-101.
Sign-up for Ignyta Receives Approval of Nonproprietary Name Entrectinib for Lead Product Candidate, RXDX-101 investment picks
CARY, N.C., Dec.
Sign-up for The Pantry Announces Fourth Quarter and Fiscal 2014 Results investment picks
Burlington Stores, Inc. (NYSE:BURL), a nationally recognized off-price retailer of high-quality, branded apparel at everyday low prices, today announced its results for the third quarter and first nine months ended November 1, 2014.
Sign-up for Burlington Stores, Inc. Announces Operating Results for the Third Quarter and Year-To-Date Period Ended November 1, 2014 investment picks
Opus Bank (“Opus”) (Nasdaq: OPB) announced today that Matt Christensen has joined Opus as Senior Managing Director, Commercial Banking – Northern California within Opus’ Commercial Bank, and as Senior Managing Director, Corporate Finance within Opus’ Merchant Bank.
Sign-up for Opus Bank Announces Expansion of Its Northern California Commercial Banking and Corporate Finance Teams investment picks
Foundation Medicine, Inc. (NASDAQ:FMI) today announced new data demonstrating that FoundationOne® Heme, developed in collaboration with Memorial Sloan Kettering Cancer Center, provides critical genomic information that can impact prognosis, influence therapeutic strategy and even refine conventional pathologic diagnosis in patients with a wide range of hematologic malignancies.
Sign-up for New Clinical Data Supports the Use of FoundationOne® Heme to Enable Informed Treatment Decisions in a Wide Range of Hematologic Malignancies investment picks
eBioscience , an Affymetrix (Nasdaq:AFFX) business, announces the availability of PrimeFlow™ RNA Assay , the first and only flow cytometry assay capable of simultaneous detection of RNA and protein within millions of cells at single-cell resolution.
Sign-up for eBioscience, an Affymetrix Business, Launches the First Assay to Detect RNA and Protein Simultaneously in Millions of Single Cells investment picks
ALBANY, N.Y., Dec.
Sign-up for AngioDynamics Awarded HealthTrust PICC Contract investment picks
Sign-up for Alderon Implements Cash Preservation Program investment picks
Sign-up for Pilot Gold Reports 10.1 g/t Gold Over 39.6 Metres at Western Flank Target, Kinsley Mountain investment picks
Integrated Device Technology, Inc. ( IDT ®) (NASDAQ:IDTI) today announced the launch of a RapidIO ® 40-100 Gbps interface product portfolio , developed to lower latency while improving bandwidth for high-performance computing (HPC), wireless, analytics and embedded applications.
Sign-up for IDT Launches RapidIO 40-100 Gbps Interface Portfolio, Reducing Latency and Boosting Bandwidth for Communications and Computing investment picks
Michael Kors Holdings Ltd.
Sign-up for UPDATE: 10 consumer companies with the best -2- investment picks
The majority of citizens surveyed by Accenture in seven countries (69 percent) say the increased use of digital technologies could improve the justice system in their countries.
Sign-up for Citizens Believe Greater use of Digital Technology can Improve Justice System, New Accenture Survey Shows investment picks
Top Etiquette Violators Include "Rear Seat Kickers," "Inattentive Parents," "The Aromatic," "The Audio Insensitive," "Boozers" and "Chatty Cathy"; 36% Would Pay Extra for Dedicated Quiet Section on Plane BELLEVUE, Wash.
Sign-up for The Sound and the Fury: Expedia Study of In-Flight Etiquette Finds "Rear Seat Kickers" Have Passed "Inattentive Parents" As America's Least-Favorite Airplane Passenger investment picks
By Jeff Reeves, MarketWatch Cruise Wall Street in a brand new car company It has been a pretty rough road for Big Auto in recent years.
Sign-up for UPDATE: Let car stocks drive your portfolio in 2015 investment picks
#1 U.S. Reviewer Has Written More Than 1,000 Reviews in 2014 NEWTON, Mass., Dec.
Sign-up for TripAdvisor Honors Its Top Contributors of 2014 investment picks
RHB-102, newly branded as BEKINDA ™ , is a proprietary once-daily oral pill formulation of the antiemetic drug ondansetron The European marketing authorization application (MAA) seeks approval of BEKINDA ™ for cancer patients suffering from chemotherapy and radiotherapy-induced nausea and vomiting BEKINDA ™ is also being developed for acute gastroenteritis and gastritis, with a Phase III study ongoing in the U.S. and top-line data expected during H2/2015 TEL-AVIV, Israel, Dec.
Sign-up for RedHill Biopharma Submits BEKINDA(TM) (RHB-102) European Marketing Authorization Application for Oncology Support investment picks
Sign-up for AgJunction's Satloc Division Debuts LiteStar III Guidance System for Aerial Application investment picks
FORT WORTH, Texas , Dec.
Sign-up for Basic Energy Services Reports Selected Operating Data For November 2014 investment picks
MetLife, Inc. (NYSE:MET) announced today that a consortium of its affiliates and third-party investor clients have provided GBP 125 million ($200 million) in financing to Angel Trains Group, the largest railway leasing company in the United Kingdom.
Sign-up for MetLife and Third Party Clients Provide GBP 125 Million Financing to the Largest Train Leasing Company in the United Kingdom investment picks
YAVNE, Israel , Dec.
Sign-up for Orbotech LT Solar Receives Follow On Orders totaling $15 Million investment picks
On the heels of recent LTE upgrades across the U.S., T-Mobile (NYSE: TMUS ) today announced that Miami, FL is the latest area to get up to a 50% increase in LTE mobile speeds from a Wideband LTE upgrade.
Sign-up for T-Mobile Increases Mobile Speeds by up to 50% in Miami investment picks
2014/12/9 (NASDAQ: AMZN) today announced the ‘Make an Offer’ experience that allows customers to negotiate even lower prices on thousands of items.
Sign-up for Amazon Unveils ‘Make an Offer’ for Customers to Negotiate Lower Prices investment picks
- Strong air transport industry fundamentals underpinning finance market health - New participants attracted by decades of predictable, attractive returns - Export credit usage to continue at historically low levels CHICAGO , Dec.
Sign-up for Boeing Forecasts Unprecedented Diversity, Efficiency for 2015 Aircraft Financing investment picks
Data suggests existing pipeline of diverse candidates can help meet demand in growing health care sector CHICAGO , Dec.
Sign-up for December Diversity Jobs Report Reveals Opportunities For Employers Seeking To Hire Women And Minorities investment picks
Net Sales increased 9 percent to $2,488 million Operating Income improved 26 percent to $202 million Adjusted EBITDA increased 17 percent to $265 million Adjusted Net Income per diluted share increased 41 percent to $0.55 (Net Income per diluted share of $0.30) ATLANTA, Dec.
Sign-up for HD Supply Holdings, Inc. Announces Fiscal 2014 Third-Quarter Results investment picks
2014/12/9 BERKELEY, CA --
Sign-up for Dynavax Announces Webcast of R&D Day investment picks
SAN LEANDRO, Calif., Dec.
Sign-up for Energy Recovery Secures Contract With ConocoPhillips investment picks
2014/12/9 Corporate Data: A Protected Asset or Ticking Time Bomb?
Sign-up for New Study: Widespread Employee Access to Sensitive Files Puts Critical Data at Risk investment picks
Forest Oil Corporation (NYSE:FST) (“Forest” or the “Company”) reported today that the New York Stock Exchange (“NYSE”) notified the Company on November 5, 2014 that it has not met the NYSE's continued listing standard that requires a minimum average closing price of $1.00 per share over 30 consecutive trading days.
Sign-up for Forest Oil Receives Continued Listing Standards Notice from the NYSE investment picks
By Shawn Langlois, MarketWatch Critical intelligence before the U.S. market opens If what went down in Shanghai is any indication of the kind of action we'll be seeing in the rest of the global markets throughout the day, this could be an uncharacteristically ugly December trading day.
Sign-up for Big trouble in China as oil's slide inspires visions of world peace investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.


Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Ignyta Receives Approval of Nonproprietary Name Entrectinib for Lead Product Candidate, RXDX-101 to Big trouble in China as oil's slide inspires visions of world peace
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent